Paper33188564
Effects of theophylline and theobromine on exercise performance and implications for competition sport: A systematic review.
Kennedy M. Drug Test Anal, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Effects of theophylline and theobromine on exercise performance and implications for competition sport: A systematic review. Papers, record 33188564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33188564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of theophylline and theobromine on exercise performance and implications for competition sport: A systematic review.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bronchodilator Agents | Major topic |
| Exercise | Major topic |
| Performance-Enhancing Substances | Major topic |
| Theobromine | Major topic |
| Theophylline | Major topic |
| Humans | |
| Sports |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42511250 | Methylxanthine Content in Green Tea Supplements: UHPLC Quantification, Method Validation, and Implications for Ergogenic Dosing in Athletes. | Foods | 2026 | https://conductscience.org/library/papers/42511250 | PubMed |
| 41440783 | Performance-Enhancing Effects of Inhaled Medications: Implications for Heart, Muscle Function, and Doping Detection in Athletes. | J Funct Morphol Kinesiol | 2025 | https://conductscience.org/library/papers/41440783 | PubMed |
| 41048238 | "Brain doping" substances: prohibited or not in sports? | Biol Sport | 2025 | https://conductscience.org/library/papers/41048238 | PubMed |
| 40049629 | Effects of Dimenhydrinate on Motor Behavior and Vascular Function: Possible Implications for the Field of Sports. | Drug Test Anal | 2025 | https://conductscience.org/library/papers/40049629 | PubMed |
| 39007997 | Influence of the CYP1A2 c.-163 A > C polymorphism in the effect of caffeine on fat oxidation during exercise: a pilot randomized, double-blind, crossover, placebo-controlled trial. | Eur J Nutr | 2024 | https://conductscience.org/library/papers/39007997 | PubMed |
| 37754829 | The Relationship between Changes in MYBPC3 Single-Nucleotide Polymorphism-Associated Metabolites and Elite Athletes' Adaptive Cardiac Function. | J Cardiovasc Dev Dis | 2023 | https://conductscience.org/library/papers/37754829 | PubMed |
| 36212869 | Metabolomic and metagenomic analyses of the Chinese mitten crab Eriocheir sinensis after challenge with Metschnikowia bicuspidata. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36212869 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33188564
GET https://conductscience.org/api/papers/v1/33188564/authors